Key result
In MDCK-D1 cells, alpha-1-adrenergic receptors stimulate arachidonic acid release through phosphorylation-dependent activation of the 85-kD cytosolic phospholipase A2 by MAP kinase subsequent to PKC activation.
This is the authors' abstract. We don't add key points for this paper.
We have characterized the mechanism whereby a G protein-coupled receptor, the alpha 1-adrenergic receptor, promotes cellular AA release via the activation of phospholipase A2 (PLA2) in Madin-Darby canine kidney (MDCK-D1) cells. Stimulation of cells with the receptor agonist epinephrine or with the protein kinase C (PKC) activator PMA increased AA release in intact cells and the activity of PLA2 in subsequently prepared cell lysates. The effects of epinephrine were mediated by alpha 1-adrenergic receptors since they were blocked by the alpha 1-adrenergic antagonist prazosin. Epinephrine- and PMA-promoted AA release and activation of the PLA2 were inhibited by AACOCF3, an inhibitor of the 85-kD cPLA2. The 85-kD cPLA2 could be immunoprecipitated from the cell lysate using a specific anti-cPLA2 serum. Enhanced cPLA2 activity in cells treated with epinephrine or PMA could be recovered in such immunoprecipitates, thus directly demonstrating that alpha 1-adrenergic receptors activate the 85-kD cPLA2. Activation of cPLA2 in cell lysates by PMA or epinephrine could be reversed by treatment of lysates with exogenous phosphatase. In addition, both PMA and epinephrine induced a molecular weight shift, consistent with phosphorylation, as well as an increase in activity of mitogen-activated protein (MAP) kinase. The time course of epinephrine-promoted activation of MAP kinase preceded that of the accumulation of released AA and correlated with the time course of cPLA2 activation. Down-regulation of PKC by overnight incubation of cells with PMA or inhibition of PKC with the PKC inhibitor sphingosine blocked the stimulation of MAP kinase by epinephrine and, correspondingly, epinephrine-promoted AA release was inhibited under these conditions. Similarly, blockade of MAP kinase stimulation by the MAP kinase cascade inhibitor PD098059 inhibited epinephrine-promoted AA release. The sensitivity to Ca2+ was similar, although the maximal activity of cPLA2 was enhanced by treatment of cells with epinephrine or PMA. The data thus demonstrate that in MDCK-D1 cells alpha 1-adrenergic receptors regulate AA release through phosphorylation-dependent activation of the 85-kD cPLA2 by MAP kinase subsequent to activation of PKC. This may represent a general mechanism by which G protein-coupled receptors stimulate AA release and formation of products of AA metabolism.
Answers are grounded in this paper and cite their sources.
This study elucidates a mechanism by which G protein-coupled receptors stimulate arachidonic acid release via PKC and MAP kinase-dependent activation of cPLA2.
No takes yet. Share an insight, caveat, or question.
Xing et al. (1996) studied In vitro cell model (MDCK-D1 cells). Epinephrine and PMA vs. Unstimulated cells or inhibitor-treated cells was evaluated on Arachidonic acid release and cPLA2 activation. In MDCK-D1 cells, alpha-1-adrenergic receptors stimulate arachidonic acid release through phosphorylation-dependent activation of the 85-kD cytosolic phospholipase A2 by MAP kinase subsequent to PKC activation.
Synapse has enriched 10 related papers. Consider them for comparative context: